MK-677 for muscle gains: what gym TikTok gets wrong
Quick answer
MK-677 (ibutamoren) is an orally active ghrelin mimetic that stimulates endogenous GH and IGF-1 secretion. At 15mg daily over 30 days in a caloric surplus, the weight gain pattern the creator described, primarily water retention and fat with modest lean tissue changes, is consistent with published pharmacology. The compound is not FDA-approved for any indication in healthy adults, and clinically relevant concerns include appetite dysregulation, fluid retention, and glucose metabolism changes that require monitoring beyond a baseline CBC.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @liftsbyfahd actually say?
The creator documented a 30-day run of MK-677 at 15mg daily, gaining 15 pounds from 180 to 195 pounds. He openly attributed the weight gain to a mix of water retention, some fat, and "lean tissue," while eating in a caloric surplus. He also disclosed getting baseline bloodwork before moving to what he called an "animal compound" next.
To his credit, he did not claim the 15 pounds was muscle. He said plainly: "a lot of that is water weight, a lot of that is some fat." He acknowledged the trade-off, noting he lost visible ab definition. He also stated he is not promoting PED use, just documenting his own journey. That framing is worth noting, even if the line between documentation and promotion gets blurry at 97K views.
The teaser for an unnamed "animal compound" coming next is concerning territory, and we will address that separately.
Does the science back this up?
The weight gain and body composition pattern he described are consistent with what MK-677 (ibutamoren) actually does in the literature. This is not a compound with a lot of controversy about its short-term effects. The controversy is about whether those effects are worth anything long-term.
MK-677 is an orally active ghrelin mimetic and growth hormone secretagogue. It reliably raises GH and IGF-1 levels. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) showed significant IGF-1 increases and lean mass gains in healthy adults over two months, but also noted increased appetite and fluid retention as consistent side effects. Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) found similar results with notable water retention. The 15-pound gain in 30 days on a caloric surplus with MK-677 is plausible. Most of that weight in four weeks being water and fat is also plausible, not a confession, just physiology.
What is less clear is how much the MK-677 actually drove the gain versus the simple caloric surplus. The compound increases appetite significantly, so the mechanism may partly be: MK-677 makes you hungry, you eat more, you gain weight. That is not the same as the drug directly building muscle.
What did they get wrong (or right)?
He got the water retention story right. That is genuinely what happens with MK-677, and he did not try to hide it or reframe it as muscle. Give him credit there.
What is missing is any acknowledgment of the relevant side effect profile beyond water retention. MK-677 has been associated with increased fasting glucose and insulin resistance, particularly with extended use. Smith et al. (2005, Journal of Clinical Endocrinology and Metabolism) found measurable increases in fasting blood glucose in older adults on ibutamoren. He mentioned getting bloodwork, which is good, but he did not tell his audience what to look for or why glucose and insulin sensitivity panels matter here.
His body fat estimates of 12 to 15 percent are unverifiable from the video and are the kind of visual guessing that fitness creators routinely get wrong by 3 to 5 percentage points. This is a minor issue but worth naming.
The "general consensus is that you use MK as a bulking agent" framing overstates community wisdom as settled science. MK-677 has not been approved by the FDA for any indication in healthy adults.
What should you actually know?
MK-677 is not approved by the FDA for use in healthy adults, and it is not a SARM despite frequent misclassification online. It is a ghrelin receptor agonist that stimulates GH release. The distinction matters because the regulatory and safety status differs from anabolic steroids and from approved medications.
The side effects that do not show up in a physique video include: increased appetite leading to fat gain on a surplus (he acknowledged this), potential insulin resistance with prolonged use, possible increases in prolactin, and water retention that can mask body composition changes entirely. For anyone with pre-existing metabolic concerns, this profile is not trivial.
- Bloodwork before starting is genuinely good practice, and he mentioned doing it. That is more than most creators doing similar content.
- The teaser about a coming "animal compound" is a red flag. Stacking unregulated compounds without medical supervision carries compounded risks that a single-compound bloodwork baseline does not adequately address.
- If you are considering any GH secretagogue, a conversation with a licensed provider who can monitor IGF-1, fasting glucose, and HbA1c is the minimum reasonable step, not a TikTok series.
The bottom line
This video is more honest than most MK-677 content on TikTok. He acknowledged water retention, fat gain, and appetite effects without dressing them up as muscle. He got bloodwork. He did not claim 15 pounds of muscle in 30 days. For the genre, that is relatively responsible. But the audience skews young, the context is a hype reel for a harder compound coming tomorrow, and the missing safety context about glucose metabolism and unregulated status is a real gap. Honest is better than dishonest. It is still not the same as safe or complete.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For MK-677 for muscle gains: what gym TikTok gets wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
MK-677 for muscle gains: what gym TikTok gets wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
MK-677 (ibutamoren) is an orally active ghrelin mimetic that stimulates endogenous GH and IGF-1 secretion.
FormBlends verdict
MK-677 (ibutamoren) is an orally active ghrelin mimetic that stimulates endogenous GH and IGF-1 secretion. At 15mg daily over 30 days in a caloric surplus, the weight gain pattern the creator described, primarily water retention and fat with modest lean tissue changes, is consistent with published pharmacology. The compound is not FDA-approved for any indication in healthy adults, and clinically relevant concerns include appetite dysregulation, fluid retention, and glucose metabolism changes that require monitoring beyond a baseline CBC.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 (ibutamoren) is an orally active ghrelin mimetic that stimulates endogenous GH and IGF-1 secretion. At 15mg daily over 30 days in a caloric surplus, the weight gain pattern the creator described, primarily water retention and fat with modest lean tissue changes, is consistent with published pharmacology. The compound is not FDA-approved for any indication in healthy adults, and clinically relevant concerns include appetite dysregulation, fluid retention, and glucose metabolism changes that require monitoring beyond a baseline CBC.
- MK-677 is not FDA-approved for use in healthy adults and is not a SARM. It is a ghrelin receptor agonist, and its regulatory status matters when evaluating sourcing and safety claims.
- Murphy et al. (1998, JCEM) confirmed that MK-677 reliably raises IGF-1 and lean mass markers but also consistently produces fluid retention and increased appetite, both of which the creator experienced and acknowledged.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- MK-677 is not FDA-approved for use in healthy adults and is not a SARM. It is a ghrelin receptor agonist, and its regulatory status matters when evaluating sourcing and safety claims.
- Murphy et al. (1998, JCEM) confirmed that MK-677 reliably raises IGF-1 and lean mass markers but also consistently produces fluid retention and increased appetite, both of which the creator experienced and acknowledged.
- Smith et al. (2005, JCEM) found measurable fasting blood glucose increases in adults on ibutamoren. A baseline CBC does not capture this risk. Glucose and insulin sensitivity panels are the relevant markers to monitor.
- The 15-pound gain over 30 days is plausible but largely attributable to water, fat, and increased caloric intake driven by appetite stimulation, not direct anabolic tissue synthesis.
- Bloodwork before starting an unregulated compound is a reasonable harm-reduction step, but the creator did not disclose which panels were run, making the 'everything looks good' claim unverifiable.
- Stacking MK-677 with an additional unspecified compound, teased at the end of this video, introduces compounded pharmacological variables that a single baseline blood draw does not address.
- Visual body fat estimates of 12 to 15 percent from video footage carry a margin of error of several percentage points and should not be treated as precise measurements without validated body composition testing.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
liftsbyfahd · TikTok creator
97.7K views on this video
Stay tuned for tmrws vid boys👀 #gym #fitness #mk677 #viral #gymtok
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by liftsbyfahd, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.